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Production of alpha/beta interferons (IFN-/) in response to viral infection is one of the main defense
mechanisms of the innate immune system. Many viruses therefore encode factors that subvert the IFN system
to enhance their virulence. Bunyamwera virus (BUN) is the prototype of the Bunyaviridae family. By using
reverse genetics, we previously produced a recombinant virus lacking the nonstructural protein NSs (BUN-
delNSs) and showed that NSs is a nonessential gene product that contributes to viral pathogenesis. Here we
demonstrate that BUNdelNSs is a strong inducer of IFN-/, whereas in cells infected with the wild-type
counterpart expressing NSs (wild-type BUN), neither IFN nor IFN mRNA could be detected. IFN induction by
BUNdelNSs correlated with activation of NF-B and was dependent on virally produced double-stranded RNA
and on the IFN transcription factor IRF-3. Furthermore, both in cultured cells and in mice lacking a functional
IFN-/ system, BUNdelNSs replicated to wild-type BUN levels, whereas in IFN-competent systems, wild-type
BUN grew more efficiently. These results suggest that BUN NSs is an IFN induction antagonist that blocks the
transcriptional activation of IFN-/ in order to increase the virulence of Bunyamwera virus.
Virus infection of mammalian cells prompts the innate im-
mune system to establish a first line of defense against the
invading pathogen. As an immediate response to infection,
cells synthesize and secrete alpha/beta interferons (IFN-/)
which prime neighboring cells to express antiviral factors,
thereby limiting the extent of virus spread (35).
IFN-/ are encoded by a single IFN- gene and a family of
closely related IFN- genes (35). In most cell types of the
peripheral tissues, IFN response commences with the produc-
tion of IFN-, which then induces the  IFNs in an autocrine
and paracrine manner. Consequently, induction of  IFNs is
severely impaired in knock-out mice that lack the IFN- gene
(8, 14), emphasizing the central role that is played by IFN-.
Induction of IFN- occurs primarily at the level of transcrip-
tional initiation and requires several regulatory factors. These
factors can be subdivided into those generally activated upon
cell stress and those more specific for IFN and other cytokine
genes. The first group consists of AP-1 and NF-B, two uni-
versal transcription factors induced upon multiple stress sig-
nals (6, 41). The second group consists of IRF-3 and IRF-7,
members of the so-called IFN-regulatory factor (IRF) family
(25, 41, 43, 46).
Key inducers of the IFN- promoter are NF-B and IRF-3
(32). Both factors can be activated by virus infection or by
double-stranded RNA (dsRNA), an intermediary of viral RNA
synthesis (22, 41, 48). Once secreted, IFN- then binds to a cell
surface receptor common to all IFN-/. This results in acti-
vation of the signal transducers and transcriptional activators
STAT1 and -2, leading to the transcription of genes that con-
tain IFN-stimulated response elements (ISRE) in their pro-
moters. These genes code for a wide array of proteins that are
antivirally active (35).
IFN-/ also have profound immunomodulatory effects and
stimulate the adaptive response. Therefore, they establish an
important link between innate and adaptive immunity (1). It is
becoming increasingly clear that, for a successful infection of
the host, viruses must have evolved strategies to subvert the
IFN system (17, 21).
The family Bunyaviridae contains several members that
cause encephalitis or hemorrhagic fevers in humans, e.g., Han-
taan, Rift Valley fever, La Crosse, and Crimean-Congo hem-
orrhagic fever viruses (13). Members of the Bunyaviridae are
enveloped viruses and have been classified into five genera:
Bunyavirus, Hantavirus, Nairovirus, Phlebovirus, and Tospovi-
rus. More than 300 named virus isolates, mainly transmitted by
arthropods, are contained within the family (12). The proto-
type of both the family Bunyaviridae and the genus Bunyavirus
is Bunyamwera virus (BUN). All members of the Bunyaviridae
have a trisegmented single-stranded RNA genome of negative
or ambisense polarity, replicate in the cytoplasm, and bud into
the Golgi apparatus (12). They encode four common structural
proteins: the viral polymerase (L) on the large (L) segment,
two glycoproteins (G1 and G2) on the medium (M) segment,
and the viral nucleocapsid protein (N) on the smallest (S)
segment. Viruses within some genera also encode nonstruc-
tural proteins, either on the M segment (termed NSm) or on
the S segment (NSs). The functions of these nonstructural
proteins are not yet fully understood.
NSs proteins are expressed by members of the Bunyavirus,
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Phlebovirus, and Tospovirus genera with different coding strat-
egies. For BUN, NSs is a small hydrophobic protein of 101
amino acids expressed from an internal, 1-shifted reading
frame within the N gene. We recently succeeded in generating
a recombinant BUN that does not express NSs (4). This virus,
named BUNdelNSs, contained specific mutations in the S seg-
ment that inactivated the NSs start codon without altering the
overlapping N reading frame. Compared to the isogenic wild-
type virus, BUNdelNSs exhibited a smaller plaque size and
grew in several cell types to approximately 10-fold-lower titers.
When inoculated by the intracerebral route, BUNdelNSs killed
BALB/c mice with a slower time course than wild-type BUN
and exhibited a reduced cell-to-cell spread. Interestingly, in
vitro experiments with transfected reporter constructs indi-
cated that BUN NSs interferes with IFN induction (4).
Here we analyzed the effects of NSs on the IFN system and
examined its role in establishing bunyavirus infection in vitro
and in vivo. The results obtained provide evidence for the
importance of NSs as a virulence factor that weakens host
defense by antagonizing the dsRNA-mediated activation of
IFN- transcription.
MATERIALS AND METHODS
Cells and viruses. Murine BF cells (9), human 293 cells, primary mouse
embryo fibroblasts (MEFs) from 129 wild-type and IFNAR0/0 mice, and simian
Vero cells were grown as monolayers in Dulbecco’s modified Eagle’s medium
(DMEM) supplemented with 10% fetal calf serum (FCS). The wild-type BUN
and BUNdelNSs (4) virus stocks used in this study were plaque purified in
BHK-21 cells, and working stocks were grown in BHK-21 cells as described
before (42).
Plasmids. Plasmid constructs for monitoring IFN- promoter activation (p-
125Luc) and NF-B activity (p55-A2Luc) and the expression construct for the
dominant-negative mutant IRF-358-427 (pEF-HAIRF358-427) were kindly pro-
vided by Takashi Fujita, Tokyo Metropolitan Institute of Medical Science, To-
kyo, Japan (46). The empty vector pEF-BOS was kindly provided by Shigekazu
Nagata, Osaka University Medical School, Osaka, Japan. The reporter construct
for monitoring ISRE activation [p(9-27)4tk(39)lucter] was kindly provided by
Stephen Goodbourn, St. George’s Hospital Medical School, London, United
Kingdom (24). The plasmid expressing the vaccinia virus E3L gene, pCMV-E3L,
was kindly provided by Robert J. Schneider, New York University School of
Medicine (15), and plasmid pAM8-1, expressing T7 RNA polymerase, was kindly
provided by Mahito Nakanishi, University of Osaka, Osaka, Japan (49). The
expression plasmids pTM1-BUNNSs and pTM1-CTRL contained the appropri-
ate coding sequences under the control of a T7 promoter and the encephalo-
myocarditis virus internal ribosome entry site (44). The control plasmid pRL-
simian virus 40 (Promega) contained the Renilla luciferase (REN-Luc) gene
under the control of the constitutive simian virus 40 promoter.
Reporter gene assays. Subconfluent monolayers of BF cells were transfected
with 1 g of firefly luciferase (FF-Luc) reporter plasmid DNAs and 0.1 g of
control plasmid pRL-SV40 in 400 l of Optimem (Gibco-BRL) containing 5 l
of DAC-30 (Eurogentech). After 5 h at 37°C, the liposome-DNA mixture was
removed, and cells were infected with 5 PFU of virus per cell. If required,
expression constructs were added to the transfection mixture, and cells were
incubated for another 24 h before infection. At 16 h postinfection, cells were
harvested and lysed in 200 l of reporter lysis buffer (Promega). An aliquot of 20
l of lysate was used to measure FF-Luc and REN-Luc activities as described by
the manufacturer (Promega). The FF-Luc activities were normalized to the
corresponding REN-Luc activities to determine induction.
Treatment with dsRNA. For transfection of cells with dsRNA, 10 g of
poly(I:C) (Sigma) was prepared with 10 l of DAC-30 liposomes (Eurogentech)
in 200 l of serum-free medium according to the manufacturers’ instructions.
After 15 min of incubation, the dsRNA-liposome mixture was dropped onto cells
without changing the medium.
Assay for IFN. Subconfluent monolayers of BF cells were infected with 5 PFU
per cell and incubated for 18 h in DMEM–10% FCS. Supernatants (2 ml) were
collected and dialyzed at 4°C two times against 100 mM glycine (pH 2) to
inactivate infectious virus and once against phosphate-buffered saline (PBS) for
pH neutralization (24 h for each dialysis step). To assay for IFN activity, 1 ml of
each of the supernatants was mixed with 1 ml of DMEM–20% FCS and laid onto
BF cells that were previously transfected with 1 g of ISRE-Luc reporter con-
struct p(9-27)4tkd(39)lucter (24) and 0.1 g of the control construct pRL-
SV40. As a standard, 1,000, 500, 100, and 0 U of human IFN- A/D (BglII) (PBL
Biomedical Laboratories) per ml, prepared in PBS, was used. The indicator cells
were then incubated for 18 h, harvested, and lysed in 200 l of reporter lysis
buffer (Promega).
An aliquot of 20 l of cell lysate was used to measure FF-Luc induced from
p(9-27)4tkd(39)lucter and REN-Luc constitutively expressed from pRL-SV40)
activities as described by the manufacturer (Promega). The ratio of FF-Luc
(reflecting IFN response) to REN-Luc (reflecting transfection efficiency) activity
was taken as a measure for IFN-/ in the supernatant. The amount of IFN
produced by the virus-infected cells was determined by comparing the normal-
ized luciferase activities with the IFN standard.
IFN-specific RT-PCR. Total RNA was extracted from infected cells with the
TriFast reagent (Peqlab). For reverse transcription (RT), 1 g of total RNA was
incubated with 200 U of Superscript II reverse transcriptase (Gibco-BRL) and
100 ng of random hexanucleotides in 20 l of 1 RT buffer (Gibco-BRL)
supplied with 1 mM each of the four deoxynucleotide triphosphates, 20 U of
RNasin, and 10 mM dithiothreitol. The resulting cDNA was amplified by 30
cycles of PCR, with each cycle consisting of 30 s at 94°C, 1 min at 58°C, and 1 min
at 72°C, followed by 10 min at 72°C. Primer sequences for amplifying mouse
-actin were from Shaw-Jackson and Michiels (34), and those for IFN- were
from Marie et al. (26).
Virus growth in tissue culture. Murine 129 wild-type and IFNAR0/0 MEFs
were grown in six-well dishes to 80% confluency and infected with 0.01 PFU per
cell, washed twice with PBS, and overlaid with DMEM–10% FCS. Supernatants
were taken at 72 h postinfection and assayed in plaque assays on Vero cells as
described before (42).
Pathogenicity studies. IFN-competent mice of inbred strain 129 and trans-
genic mice with targeted disruptions of the  subunit of the IFN-/ receptor
(IFNAR0/0) (28) on an 129 background were obtained from B&K Universal Ltd.
(United Kingdom). Five-week-old specific-pathogen-free female mice were in-
oculated either intraperitoneally or intracerebrally with virus. For intraperitoneal
infection, 1,000 PFU of virus was inoculated in 0.1 ml of PBS containing 0.75%
(wt/vol) bovine serum albumin (PBSA). For intracerebral infection, 1,000 PFU
of virus was inoculated in 0.02 ml of PBSA. The animals were monitored twice
daily over an 8-day period. Mice that were moribund or severely paralyzed were
killed.
RESULTS
Induction of IFN-/ by BUNdelNSs. To measure IFN-/
production of infected cells, we used a bioassay based on trans-
fected reporter plasmids. Mouse fibroblasts were infected with
wild-type BUN or BUNdelNSs and incubated overnight, and
supernatants were depleted of infectious virus by acidification.
To assay for IFN-/ activity, indicator cells previously trans-
fected with an IFN-responsive (ISRE) reporter plasmid were
incubated with the treated supernatants. The amount of firefly
luciferase produced from the ISRE construct was linearly de-
pendent on the amount of IFN in the supernatant (data not
shown). Therefore, the concentration of IFN could be deter-
mined by comparing ISRE activity in indicator cells with a
standard curve. Figure 1A shows that supernatants from wild-
type BUN-infected cells did not contain detectable amounts
(i.e., below 50 U) of IFN-/, similar to the situation with
mock-infected cells. By contrast, cells infected with BUN-
delNSs produced more than 1,000 U of IFN-/ per ml of
medium.
It is conceivable that, in wild-type BUN-infected cells, NSs
interferes with the synthesis of IFN by blocking the transcrip-
tion of the IFN gene, whereas BUNdelNSs is unable to hinder
transactivation. Alternatively, the IFN gene could be induced
in wild-type BUN- and BUNdelNSs-infected cells to the same
extent, but NSs inhibits a posttranscriptional step, e.g., trans-
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lation of the IFN mRNA. To distinguish between these possi-
bilities, we analyzed the infected cells for the presence of
IFN-mRNA by RT-PCR. In Fig. 1B (upper panel) it is shown
that in cells infected with BUNdelNSs, an RT-PCR signal
specific for IFN- could be detected. By contrast, cells infected
with wild-type BUN did not give rise to an RT-PCR signal,
similar to mock-infected cells. The signal is due to the presence
of IFN- mRNA and not any residual genomic DNA in the
RNA preparation, since PCR without a preceding RT step was
negative.
Similarly, the water control did not give rise to a specific
signal, indicating the absence of contamination. Figure 1B
(lower panel) shows that -actin mRNA was detected in all RT
reactions, but not in the PCR only or the H2O control, indi-
cating that all preparations contained similar amounts of RNA.
Taken together, the results demonstrate that IFN- mRNA is
strongly synthesized and translated in cells infected with BUN-
delNSs but not in cells infected with wild-type BUN, suggesting
that NSs interferes with transcriptional activation of the IFN-
promoter.
Activation of NF-B and IRF-3. We investigated the involve-
ment of NF-B and IRF-3, two key transcription factors, in the
induction of IFN- by BUNdelNSs. For NF-B, we took ad-
vantage of a reporter construct containing the NF-B binding
sequence from the IFN- promoter, situated upstream of an
FF-Luc reporter gene (46). Cells were transfected with the
reporter constructs and infected with bunyaviruses. For the
reporter assays, we chose an early time point postinfection to
exclude the possibility that NF-B is simply activated by the
induced IFN (45). In Fig. 2A it is shown that BUNdelNSs
activated the NF-B reporter by a small but reproducible de-
gree as early as 4 h postinfection, whereas in wild-type BUN-
and mock-infected cells, no such activity was detected. These
results suggest that the presence of the NSs gene product
interferes with the activation of NF-B.
A different approach was followed to investigate IRF-3 ac-
tivation. Upon infection with Newcastle disease virus, IRF-3 is
essential for the activation of the IFN- promoter, and block-
ing its activity results in a loss of IFN- inducibility (46). We
transfected a reporter construct containing FF-Luc under con-
trol of an IFN- promoter together with an expression con-
struct for a dominant-negative IRF-3 mutant, IRF-358-427 (46),
and assayed for activation of the IFN- promoter by bunyavi-
rus infection. In a parallel experiment, the IRF-358-427 con-
struct was replaced with the parental expression vector pEF-
FIG. 1. IFN induction in infected mouse BF cells. (A) IFN-/ in
supernatants. Murine BF cells were either mock infected or infected
with 5 PFU of wild-type BUN or BUNdelNSs per cell and incubated
for 18 h. Supernatants were collected, and IFN concentration was
determined. (B) Detection of IFN- mRNA. Total RNA was extracted
from the cells used in panel A, reverse transcribed with random hex-
anucleotide primers, and PCR amplified with primers specific for
mouse IFN- (upper panel) or -actin (lower panel). Cells were either
mock infected (lane m) or infected with wild-type BUN (lane wt) or
BUNdelNSs (lane delNSs). As controls, water (lane A) or total RNA
from BUNdelNSs-infected cells without a preceding RT step [lane ()
RT] were used for PCR-amplification.
FIG. 2. Involvement of IFN transcription factors NF-B and IRF-3. (A) NF-B. Murine BF cells were transfected with the NF-B reporter
plasmid p-125Luc. At 5 h after transfection, the cells were either mock infected or infected with wild-type BUN (wtBUN) or BUNdelNSs. Four
hours after infection, firefly luciferase activities in cell lysates were measured. (B) IRF-3. Murine BF cells were transfected with the IFN- reporter
plasmid along with the parental vector pEF-BOS or a plasmid expressing a dominant-negative IRF-3 mutant (IRF358-427). At 24 h after
transfection, the cells were either mock infected or infected with wild-type BUN or BUNdelNSs. Eighteen hours after infection, firefly luciferase
activities in the cell lysates were measured. In this and subsequent figures, bars indicate standard error from the results of three experiments.
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BOS. Figure 2B shows that BUNdelNSs was capable of
activating the IFN- promoter of the FF-Luc reporter gene,
whereas wild-type BUN was not. Coexpression of the IRF-358-427
mutant, however, resulted in a significant loss of activation by
the BUNdelNSs virus. These data demonstrate that IRF-3 is
required for IFN- induction by the mutant virus. Therefore,
the induction of IFN- by BUNdelNSs follows the classical
model involving NF-B and IRF-3.
Involvement of dsRNA. A common activator of NF-B and
IRF-3 is dsRNA, a by-product of viral RNA polymerases (23).
We were interested to see whether dsRNA is also involved in
IFN induction by BUNdelNSSs. For this purpose, we used
E3L, an IFN antagonist encoded by vaccinia virus that binds to
dsRNA with high affinity (5). Similar to the experiment with
the dominant-negative IRF-3 mutant (see Fig. 2B), we coex-
pressed E3L in cells transfected with the IFN- reporter con-
struct. Figure 3 shows that coexpression of E3L did prevent the
activation of the IFN- promoter by BUNdelNSs, whereas a
cotransfected control construct had no influence. These data
suggest that virally produced dsRNA is the trigger for IFN
induction by BUNdelNSs.
Expression of NSs blocks activation of the IFN- promoter.
To determine whether NSs on its own was able to inhibit IFN
synthesis, we investigated its influence on the activation of the
IFN- promoter in a virus-free system. Cells were transfected
with the IFN- promoter reporter construct along with plas-
mids expressing either NSs or the Renilla luciferase gene as a
control. Subsequently, IFN synthesis was induced by transfec-
tion with dsRNA. Figure 4 shows that activation of the IFN-
promoter was observed only in control-transfected cells, but
not when NSs was expressed. This indicates that BUN NSs is
sufficient to suppress induction of IFN-/ by dsRNA and that
no other viral gene products are needed for its function.
Growth of viruses in IFN-deficient cells. Several bunyavi-
ruses are known to be sensitive to the effects of IFN (16, 31,
39). It was therefore possible that because of the high levels of
IFN induced by BUNdelNSs, the mutant virus has a reduced
growth rate in IFN-competent cells. We used primary mouse
embryo fibroblasts (MEFs) which were derived from trans-
genic 129 mice either with (wild-type MEFs) or without (IF-
NAR0/0 MEFs) (28) the  subunit of the IFN-/ receptor as
an experimental system. Since these cells have the same ge-
netic background, any observed differences can clearly be as-
cribed to the presence or absence of the functional IFN system.
As a first step, we investigated the ability of wild-type BUN
and BUNdelNSs to form plaques on these cells. Figure 5A
shows that on IFNAR0/0 MEFs, both wild-type BUN and
BUNdelNSs were able to form plaques, with the delNSs mu-
tant having a reduced plaque size. By contrast, on the wild-type
MEFs, wild-type BUN but not BUNdelNSs was able to form
plaques. To further characterize this effect, cells were infected
with wild-type BUN or BUNdelNSs, and virus titers in the
supernatants were measured at 72 h postinfection. In Fig. 5B it
FIG. 3. Effect of dsRNA-binding protein E3L on IFN- promoter
induction by BUNdelNSs. Murine BF cells were transfected with the
IFN- promoter containing reporter plasmid p-125Luc along with 1 g
each of the parental vector pEF-BOS or a plasmid encoding E3L. At
24 h after transfection, the cells were either mock infected or infected
with wild-type BUN (wtBUN) or BUNdelNSs. Eighteen hours after
infection, firefly luciferase activities in cell lysates were measured.
FIG. 4. Effect of NSs on induction of IFN-/ promoter. Human
293 cells were transfected with the IFN- promoter containing re-
porter plasmid p-125Luc (encoding firefly luciferase) along with 0.5 g
each of a T7 polymerase expression plasmid and T7-driven constructs
expressing BUN NSs or a control protein (lanes CTRL). At 24 h after
transfection, the cells were mock treated (Renilla luciferase, bars m) or
transfected with dsRNA, and 18 h later, firefly (black bars) and Renilla
(gray bars) luciferase activities in cell lysates were measured.
FIG. 5. Growth of viruses in IFN-deficient cells. (A) Comparison
of plaques produced by wild-type BUN (wt BUN) and the BUNdelNSs
mutant in mouse embryo fibroblasts derived from 129 wild-type mice
(wt MEFs) or IFNAR knock-out mice (IFNAR0/0 MEFs). Cells were
infected with approximately 5  103, 5  102, or 5  101 PFU per dish
and fixed and stained 72 h postinfection. (B) Virus titers in wild-type
MEFs and IFNAR0/0 MEFs. Cells were infected at 0.01 PFU per cell,
and the virus concentration in the supernatants was measured 72 h
after infection.
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is shown that, on IFNAR0/0 MEFs, the difference between
wild-type BUN and BUNdelNSs was less than 10-fold. On
wild-type MEF cells, however, the difference was significantly
more, reaching approximately 1,000-fold. The apparent slight
reduction in yield of wild-type BUN on wild-type MEFs prob-
ably reflects a very low level of IFN induction upon prolonged
incubation. These findings demonstrate that the lack of NSs
expression led to severe growth restrictions for BUN in IFN-
competent cells but had no significant effect in cells lacking an
IFN system.
Virulence of wild-type and delNSs bunyaviruses in mice
with a compromised IFN system. We then assessed a possible
role of virally induced IFN-/ in vivo, in order to investigate
the function of NSs as a virulence factor. For this purpose, we
used the mouse system corresponding to the cells mentioned
above, namely, 129 wild-type mice and 129 IFNAR0/0 mice.
Groups of mice were inoculated intraperitoneally with wild-
type BUN or BUNdelNSs and observed for survival. Wild-type
mice infected with any of the viruses did not develop symp-
toms. By contrast, none of the IFNAR0/0 mice survived for
longer than 96 h following inoculation with either virus. To
investigate this further, mice were inoculated intracerebrally
and observed for survival. Wild-type 129 mice succumbed to
both viruses, but with a clear difference in disease progression.
When infected with wild-type BUN, the majority of mice died
after 5 days, whereas most of the mice inoculated with BUN-
delNSs survived for at least 3 days longer (Fig. 6A). In IF-
NAR0/0 mice, however, this difference was significantly re-
duced, and both viruses killed their hosts within 3 to 4 days
(Fig. 6B).
These data demonstrate that both viruses are equally viru-
lent if the IFN system is absent, strongly indicating that NSs
also acts in vivo as an IFN antagonist.
DISCUSSION
In this study, two Bunyamwera viruses which differ geneti-
cally by the presence of the NSs reading frame were compared
for their ability to interact with the IFN system. The results
presented establish that BUN NSs blocks transcriptional acti-
vation of IFN-/. NSs was found to be of advantage for virus
multiplication, but only in cells and animals with a functional
IFN-/ system. Thus, BUN NSs can be designated an IFN
antagonist.
Anti-IFN activity has been described for accessory proteins
of several other negative-stranded RNA viruses (17, 21). In
general, such activities can be distinguished as those interfer-
ing with the immediate-early step, induction of IFN (like BUN
NSs), and those interfering with the late step, activation of
IFN-responsive genes. For simplicity, we propose to designate
these factors IFN induction antagonists and IFN response an-
tagonists, respectively. Most factors of negative-stranded RNA
viruses characterized so far belong to the second group. For
example, the V protein of simian virus 5, a member of the
Paramyxoviridae family, inhibits the activation of IFN-respon-
sive genes by targeting STAT1 for proteasome-mediated deg-
radation (10). Similarly, the C protein of Sendai virus, another
paramyxovirus, inhibits STAT1 activation by hampering phos-
phorylation (47) and increasing instability (20). Bovine respi-
ratory syncytial virus, also a member of the Paramyxoviridae,
encodes two nonstructural proteins (NS1 and NS2) that coop-
eratively mediate resistance to the antiviral actions of IFN
(33). These examples illustrate that many negative-stranded
RNA viruses have evolved mechanisms to block IFN response
in order to survive in the infected cell by hindering activation
of antiviral genes.
A different strategy is followed by the IFN induction antag-
onists. In this case, viruses inhibit the production of IFN-/,
thus hiding in the host and avoiding a systemic alert that would
trigger the innate as well as the adaptive immune response.
One of the best-characterized examples is the nonstructural
protein NS1 of influenza A virus. Similar to BUN NSs (Fig. 5
and 6), NS1 of influenza A virus was found to be dispensable
for growth in IFN-deficient cells and mice (11, 18). The induc-
tion of IFN-/ is prevented by inhibiting the activation of
NF-B (40) and IRF-3 (37), most probably by the ability of
NS1 to sequester dsRNA (40). We have found that BUN NSs
also prevents activation of NF-B (Fig. 2A) and IRF-3 (Fig.
2B) and that dsRNA plays a role in induction by the mutant
virus (Fig. 3). This could suggest that BUN NSs and influenza
A virus NS1 have similar strategies to accomplish IFN inhibi-
tion. There is, however, no significant sequence similarity be-
tween these two polypeptides. Furthermore, no dsRNA bind-
ing could be detected for BUN NSs (F. Weber, unpublished
results). Thus, although recombinant BUN and influenza A
viruses lacking the NSs or NS1 gene, respectively, both induce
IFN by a signal transduction pathway involving dsRNA, NF-
B, and IRF-3, fundamental differences appear to exist in the
molecular mechanism of the respective IFN induction antag-
onists.
The NSs protein of Rift Valley fever virus, a member of the
Phlebovirus genus in the Bunyaviridae family, was also identi-
fied as an IFN induction antagonist. It was shown that viruses
containing mutations in the NSs gene are strong IFN inducers
FIG. 6. Virulence of viruses in 129 wild-type (A) and IFNAR0/0
(B) mice. Groups of six 5-week-old female mice were inoculated in-
tracerebrally with 1,000 PFU of wild-type BUN (wt BUN) or BUN-
delNSs virus. The animals were monitored for 8 days. Mice that were
moribund or severely paralyzed were killed and scored dead on that day.
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and able to grow only in mice with a compromised IFN-/
system (2). Although the authors could not formally exclude
the influence of additional mutations present on the NSs-car-
rying gene segment, the results strongly imply that NSs is the
factor responsible for suppression of IFN induction in wild-
type Rift Valley fever virus-infected animals. However, it is not
known whether Rift Valley fever virus NSs influences NF-B
and IRF-3, or whether a later step in IFN production is
blocked.
It can be speculated that IFN antagonism is a general fea-
ture of the NSs proteins of the Bunyavirus and Phlebovirus
genera. Members of the Tospovirus genus, which are patho-
genic for plants, also encode NSs proteins. Of note, it has been
described that dsRNA also plays a role in the defense system
of plants against viral pathogens (27). There is, however, a
great difference in size, amino acid sequence, and coding strat-
egy between the proteins designated NSs in the different Bu-
nyaviridae genera (12). It is therefore conceivable that the NSs
proteins evolved independently but in adaptation to a common
selection pressure, e.g., the mammalian IFN system. On the
other hand, members of both the Hantavirus and Nairovirus
genera do not encode a nonstructural protein in their S seg-
ment. To our knowledge, no data on IFN induction are avail-
able for any member of the Nairovirus genus, but for hantavi-
ruses it was found that infection indeed induces IFN- (30)
and activates IRF-3 and NF-B (36). Thus, it is possible that
bunyaviruses without an NSs gene product may use other strat-
egies to escape the host defense.
In general, negative-stranded viruses, which include many
important pathogens, have a relatively small genome with a
limited set of genes. Nevertheless, recent advances in reverse
genetics technologies (3, 7, 19, 29) revealed that some gene
products, often nonstructural proteins, are not essential for
virus growth in cell culture but constitute “luxury” functions
increasing virulence. Rationally designed virus mutants lacking
these genes are promising candidates for live vaccines, since
they can be grown to high titers in IFN-deficient cells but are
attenuated in the host. This has been exemplified for influenza
A and B viruses (38) and may also be a possibility for human-
pathogenic members of the Bunyaviridae family.
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